Teleflex Says FDA Grants Clearance for Expanded Indications of QuikClot Control+ Hemostatic Device

MT Newswires Live

2025/04/30

Teleflex (TFX) said Wednesday that the US Food and Drug Administration gave 501(k) clearance for expanded use of the QuikClot Control+ hemostatic device to include all grades of internal and external bleeding.

The expanded clearance covers procedures in general surgery, gynecologic surgery, orthopedic surgery and other areas, the company added.

The expanded use will add more than $150 million to the company's serviceable addressable market in the US, according to Teleflex.

Shares of the company were down 3% in recent trading.

Price: 134.33, Change: -3.89, Percent Change: -2.81

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2531051575"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2531051575\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2531051575?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-30 22:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2531051575","market":"sh","top_or_hot":-1,"title":"Teleflex Says FDA Grants Clearance for Expanded Indications of QuikClot Control+ Hemostatic Device","media":"MT Newswires Live","content":"<html><body><p> Teleflex (TFX) said Wednesday that the US Food and Drug Administration gave 501(k) clearance for expanded use of the QuikClot Control+ hemostatic device to include all grades of internal and external bleeding.</p><p>The expanded clearance covers procedures in general surgery, gynecologic surgery, orthopedic surgery and other areas, the company added.</p><p>The expanded use will add more than $150 million to the company's serviceable addressable market in the US, according to Teleflex.</p><p>Shares of the company were down 3% in recent trading.</p><p>Price: 134.33, Change: -3.89, Percent Change: -2.81</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teleflex Says FDA Grants Clearance for Expanded Indications of QuikClot Control+ Hemostatic Device</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeleflex Says FDA Grants Clearance for Expanded Indications of QuikClot Control+ Hemostatic Device\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-30 22:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Teleflex (TFX) said Wednesday that the US Food and Drug Administration gave 501(k) clearance for expanded use of the QuikClot Control+ hemostatic device to include all grades of internal and external bleeding.</p><p>The expanded clearance covers procedures in general surgery, gynecologic surgery, orthopedic surgery and other areas, the company added.</p><p>The expanded use will add more than $150 million to the company's serviceable addressable market in the US, according to Teleflex.</p><p>Shares of the company were down 3% in recent trading.</p><p>Price: 134.33, Change: -3.89, Percent Change: -2.81</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4504","symbol_name":"桥水持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2531051575","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2531051575","pubTimestamp":1746023130,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Teleflex  said Wednesday that the US Food and Drug Administration gave 501 clearance for expanded use of the QuikClot Control+ hemostatic device to include all grades of internal and external bleeding.The expanded clearance covers procedures in general surgery, gynecologic surgery, orthopedic surgery and other areas, the company added.The expanded use will add more than $150 million to the company's serviceable addressable market in the US, according to Teleflex.Shares of the company were down 3% in recent trading.Price: 134.33, Change: -3.89, Percent Change: -2.81","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4504":"桥水持仓","TFX":"泰利福","BK4082":"医疗保健设备","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"Teleflex表示FDA批准QuikClot Control+止血装置的扩大适应症","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TFX":1},"content_text":"Teleflex (TFX) said Wednesday that the US Food and Drug Administration gave 501(k) clearance for expanded use of the QuikClot Control+ hemostatic device to include all grades of internal and external bleeding.The expanded clearance covers procedures in general surgery, gynecologic surgery, orthopedic surgery and other areas, the company added.The expanded use will add more than $150 million to the company's serviceable addressable market in the US, according to Teleflex.Shares of the company were down 3% in recent trading.Price: 134.33, Change: -3.89, Percent Change: -2.81","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}